-
In this issue: Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.
-
-
Kost and colleagues provide updated contraceptive failure rates derived from the 2002 National Survey of Family Growth.
-
-
Medicare's Important Message (IM) has been around for years, but a change to the rule and the process for imparting the IM has thrown many in discharge planning for a loop.
-
Changes to Medicare's Important Message (IM), informing patients of their rights to Medicare services and to question discharge decisions, which went into effect in July 2007, coincided with a revamping of the hospital-issued notices of noncoverage (HINNs) that notify patients of their financial responsibility if they receive services not covered by Medicare.
-
-
The blurring of lines between the role of social worker and nurse case manager in discharge planning has been the source of tension between the two specialties for more than two decades. But one expert says some organizations spend perhaps a little too much time defining roles and too little time figuring out ways to share responsibility.
-
CMS offers clarification on HIPAA medical privacy rule; 'Medicare should cover care coordination services'
-
There is little doubt that the budget problems and added demand on limited resources that undocumented immigrants contribute to health care institutions is real, and that institutions located closest to the border bear the greatest burden.
